Fletikumab Uses, Dosage, Side Effects and more
Fletikumab is under investigation in clinical trial NCT01038674 (Safety and Tolerability of Anti-IL-20 in Subjects With Rheumatoid Arthritis).
| Trade Name | Fletikumab |
| Generic | Fletikumab |
| Fletikumab Other Names | Anti-IL-20, Fletikumab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
